Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Vitamin supplementation in adult coeliac disease patients
ISRCTN ISRCTN42241118
ClinicalTrials.gov identifier
Public title Vitamin supplementation in adult coeliac disease patients
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Vitamin supplementation for six months will normalize biochemical markers, general well-being and gastrointestinal symptoms in adults with longstanding coeliac disease
Lay summary
Ethics approval Approved by the Linkoping University Ethics Committee, Linkoping, Sweden on 19/05/2004, reference number: 44/04
Study design Randomised, double-blind, parallel, placebo-controlled study
Countries of recruitment Sweden
Disease/condition/study domain Adult coeliac disease under dietary treatment
Participants - inclusion criteria 1. Men and women aged 45-64 yrs with a biopsy-proven coeliac disease treated for at least 8 years and in proven remission
2. Declaration of keeping a strict gluten free diet
3. Written informed consent
Participants - exclusion criteria 1. Concomitant serious disease
2. Hypersensitivity to B-vitamins
3. Positive coeliac disease serology
4. Unable to comply with protocol
5. Previous small intestinal resection
6. Vitamin supplementation during last three months
7. Concomitant phenobarbital, phenytoin, methotrexate and/or trimethoprim
Anticipated start date 15/12/2003
Anticipated end date 28/11/2005
Status of trial Completed
Patient information material
Target number of participants 65
Interventions A daily dose of TrioBe® (800 ug folic acid, 500 ug cyanocobalamin, 3 mg pyridoxine) versus placebo for six months
Primary outcome measure(s) To determine if plasma total homocysteine, a marker of vitamin deficiency, could be normalized by six months of vitamin supplementation
Secondary outcome measure(s) To determine if psychological general well-being or gastrointestinal symptoms could be normalized by six months of vitamin supplementation
Sources of funding Recip AB
Trial website
Publications
Contact name Prof  Claes  Hallert
  Address NSÖ stab
Vrinnevisjukhuset
  City/town Norrköping
  Zip/Postcode S-601 82
  Country Sweden
Sponsor Recip AB (Sweden)
  Address 7 Lagervägen
  City/town Haninge
  Zip/Postcode S-136 50
  Country Sweden
  Sponsor website: http://www.recip.se
Date applied 16/03/2006
Last edited 21/04/2006
Date ISRCTN assigned 21/04/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central